| 000 | 01045 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517084126.0 | ||
| 264 | 0 | _c20170329 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2016.02.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTalmadge, James E | |
| 245 | 0 | 0 |
_aNatural product derived immune-regulatory agents. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cAug 2016 |
||
| 300 |
_a5-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aBiological Products _xpharmacology |
| 650 | 0 | 4 |
_aCommunicable Diseases _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xpharmacology |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aOff-Label Use |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 37 _gp. 5-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2016.02.025 _zAvailable from publisher's website |
| 999 |
_c25819674 _d25819674 |
||